SCHEMBL7743643

SCHEMBL7743643

CC(C)N(C(C)C)C([O])CC#N

nearest known ligand 0.32

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.32
CYP1A2 P05177 1/20 0.31
MAPK1 P28482 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7454401 0.74 TSHR (0.35) TSHRCYP1A2MAPK1
SCHEMBL8191870 0.70 TSHR (0.32) TSHRCYP1A2MAPK1
SCHEMBL27294287 0.70 TSHR (0.32) TSHRCYP1A2MAPK1
SCHEMBL6751655 0.69
SCHEMBL7906814 0.69
SCHEMBL8883207 0.68 TSHR (0.31) TSHRCYP1A2MAPK1
SCHEMBL5244719 0.67 TSHR (0.30) TSHR
SCHEMBL153525 0.67 TSHR (0.30) TSHR
SCHEMBL28630073 0.66
SCHEMBL7191400 0.65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1109825-A4 IMPROVED PROCESS FOR THE SYNTHESIS OF OLIGONUCLEOTIDES INCORPORATING 2-AMINOADENOSINE ISIS PHARMACEUTICALS INC (US) 2001-09-05 EP disclosed
EP-1109825-A1 IMPROVED PROCESS FOR THE SYNTHESIS OF OLIGONUCLEOTIDES INCORPORATING 2-AMINOADENOSINE ISIS PHARMACEUTICALS, INC. (US) 2001-06-27 EP disclosed
WO-2000012563-A1 IMPROVED PROCESS FOR THE SYNTHESIS OF OLIGONUCLEOTIDES INCORPORATING 2-AMINOADENOSINE ISIS PHARMACEUTICALS, INC. (US) 2000-03-09 WO disclosed
WO-1999010365-A2 5',5'-LINKED OLIGOMERS HAVING ANTI-THROMBIN ACTIVITY GILEAD SCIENCES, INC. (US) 1999-03-04 WO disclosed